pd 142893 has been researched along with cyclosporine in 2 studies
| Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 64 | 0 | 3 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cody, WL; Davis, LS; Doherty, AM; Haleen, SJ; Keiser, JA | 1 |
| Bruch, D; Kittur, DS; Kittur, S; Ondocin, P; Shah, G; Wilasrusmee, C; Wilasrusmee, S | 1 |
2 other study(ies) available for pd 142893 and cyclosporine
| Article | Year |
|---|---|
Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A.
Topics: Animals; Blood Pressure; Cyclosporine; Endothelin Receptor Antagonists; Hemodynamics; Kidney; Male; Oligopeptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renal Circulation; Vascular Resistance | 1994 |
Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor.
Topics: Animals; Antibodies; Capillaries; Cyclosporine; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Kidney; Mice; Mice, Inbred C3H; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Oligopeptides; Survival Analysis | 2003 |